Publications

Inflammaging, a targetable pathway for preventing cardiovascular disease

Juan Francisco Aranda , Cristina M Ramírez , María Mittelbrunn

 

DOI: 39530590
PMID: 10.1093/cvr/cvae240

Inflammaging, characterized by persistent chronic inflammation in older adults, has emerged as a critical factor linked to age-related diseases such as cardiovascular diseases (CVDs), metabolic disorders, and cognitive decline, which collectively contribute to the leading causes of death globally. Elevated levels of cytokines, chemokines, and others inflammatory mediators characterize inflammaging and serve as indicators of

Warburg Effect Reshapes Tumor Immunogenicity.

José A Enríquez , María Mittelbrunn

Tumor cells rewire their metabolism to fulfill the demands of highly proliferative cells. This changes cellular metabolism to adapt to fuel and oxygen availability for energy production and to increase the synthesis capacity of building blocks for cell division and growth. In addition, the metabolic shift modulates the immunogenicity of the tumor cells. Recently, Mahmood

Nicotinamide adenine dinucleotide metabolism in the immuneresponse, autoimmunity and inflammageing

Navarro MN, Gómez de Las Heras MM, Mittelbrunn M.

Br J Pharmacol. 2022 May;

179(9):1839-1856.
doi: 10.1111/bph.15477.
PMID: 33817782 .

Metabolism is dynamically regulated to accompany immune cell function, and altered immunometabolism can result in impaired immune responses. Concomitantly, the pharmacological manipulation of metabolic processes offers an opportunity for therapeutic intervention in inflammatory disorders. The nicotinamide adenine dinucleotide (NAD+ ) is a critical metabolic intermediate that serves as enzyme cofactor in redox reactions, and is